{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Arm+3+intervention&page=107", "query": { "intervention": "Arm 3 intervention", "page": 107 }, "page_size": 10 }, "pagination": { "page": 107, "page_size": 10, "total_count": 3768, "total_pages": 377, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Arm+3+intervention&page=108&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Arm+3+intervention&page=106&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T22:29:44.461Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05288452", "title": "Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Digital Health Coaching", "type": "BEHAVIORAL" }, { "name": "Food Box Delivery", "type": "DIETARY_SUPPLEMENT" }, { "name": "Remote Patient Monitoring (RPM)", "type": "BEHAVIORAL" }, { "name": "Diabetes Education Class", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "DIETARY_SUPPLEMENT" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 304, "start_date": "2023-01-05", "completion_date": "2026-08-30", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05288452" }, { "nct_id": "NCT02220985", "title": "Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Biphenotypic Leukemia", "Acute Leukemia of Ambiguous Lineage", "Acute Undifferentiated Leukemia", "Allogeneic Hematopoietic Stem Cell Transplant Recipient", "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Blastic Plasmacytoid Dendritic Cell Neoplasm", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Donor", "Lymphoblastic Lymphoma", "Myelodysplastic Syndrome With Excess Blasts", "Myelodysplastic Syndrome With Excess Blasts-1", "Myelodysplastic Syndrome With Excess Blasts-2", "Recurrent Acute Lymphoblastic Leukemia", "Recurrent Acute Myeloid Leukemia", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Refractory Acute Lymphoblastic Leukemia", "Refractory Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission" ], "interventions": [ { "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" }, { "name": "Total-Body Irradiation", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "RADIATION" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "60 Years", "sex": "ALL", "summary": "Up to 60 Years" }, "enrollment_count": 84, "start_date": "2015-03-23", "completion_date": "2025-05-01", "has_results": true, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 2, "location_summary": "Pittsburgh, Pennsylvania • Seattle, Washington", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02220985" }, { "nct_id": "NCT04216316", "title": "Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lung Non-Small Cell Squamous Carcinoma", "Stage IV Lung Cancer AJCC v8" ], "interventions": [ { "name": "Berzosertib", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2021-04-14", "completion_date": "2027-03-18", "has_results": true, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 34, "location_summary": "Los Angeles, California • Newport Beach, California • Aventura, Florida + 25 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04216316" }, { "nct_id": "NCT06156215", "title": "PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Vaccine Messaging", "type": "BEHAVIORAL" }, { "name": "Vaccine Acceptance Question", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 919, "start_date": "2024-01-19", "completion_date": "2024-08-18", "has_results": true, "last_update_posted_date": "2025-09-12", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 7, "location_summary": "San Francisco, California • Durham, North Carolina • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06156215" }, { "nct_id": "NCT02335138", "title": "Project Nexus: Providing Online Counseling for Home-Based HIV Testing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Couples" ], "interventions": [ { "name": "Couples HIV Testing and Counseling (CHTC, CVCT)", "type": "BEHAVIORAL" }, { "name": "at-home test kit", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 800, "start_date": "2016-04", "completion_date": "2019-09-30", "has_results": false, "last_update_posted_date": "2019-10-21", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02335138" }, { "nct_id": "NCT05570448", "title": "Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gastro Esophageal Reflux" ], "interventions": [ { "name": "ARAT", "type": "PROCEDURE" }, { "name": "Sham intervention (control)", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Midwest Veterans' Biomedical Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 36, "start_date": "2022-02-15", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05570448" }, { "nct_id": "NCT03522155", "title": "Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Cancer Stage I", "Kidney Cancer Stage I", "Bladder Cancer Stage II", "Prostate Cancer Stage II" ], "interventions": [ { "name": "Patient-centered communication of life expectancy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 136, "start_date": "2021-09-01", "completion_date": "2023-09-30", "has_results": false, "last_update_posted_date": "2020-02-06", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03522155" }, { "nct_id": "NCT01849978", "title": "Enhancing Exercise in Breast Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Newsletter about physical activity and breast cancer survivors", "type": "BEHAVIORAL" }, { "name": "Changing your habits brochure", "type": "BEHAVIORAL" }, { "name": "Tips for making exercise enjoyable and personally-valued", "type": "BEHAVIORAL" }, { "name": "Testimonials from breast cancer survivors", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2014-05", "completion_date": "2015-04", "has_results": false, "last_update_posted_date": "2016-01-14", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01849978" }, { "nct_id": "NCT07393555", "title": "Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Lung Non-Small Cell Carcinoma", "Stage IV Lung Cancer AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Ivonescimab", "type": "BIOLOGICAL" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Sacituzumab Govitecan", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 117, "start_date": "2026-09-22", "completion_date": "2029-11", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 41, "location_summary": "Berkeley, California • Palo Alto, California • Sacramento, California + 35 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Gainesville", "state": "Georgia" }, { "city": "Coeur d'Alene", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT07393555" }, { "nct_id": "NCT01267019", "title": "Social Cognition Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psychosis" ], "interventions": [ { "name": "social cognitive training with in vivo augmentation", "type": "BEHAVIORAL" }, { "name": "social cognitive training", "type": "BEHAVIORAL" }, { "name": "non-social skills training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 153, "start_date": "2011-02", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-03-15", "last_synced_at": "2026-11-06T22:29:44.461Z", "location_count": 1, "location_summary": "West Los Angeles, California", "locations": [ { "city": "West Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01267019" } ] }